产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
---|---|---|---|---|
A998883 | Anti-IL-6 / IFNb2 Reference Antibody (siltuximab), Anti-IL-6 / IFNb2 Reference Antibody (siltuximab), |
|||
A998884 | Anti-IL-6 / IFNb2 Reference Antibody (sirukumab), Anti-IL-6 / IFNb2 Reference Antibody (sirukumab), |
|||
A998885 | Anti-IL-6 / IFNb2 Reference Antibody (ziltivekimab), Anti-IL-6 / IFNb2 Reference Antibody (ziltivekimab), |
|||
A998886 | Anti-IL-6Ra / CD126 Reference Antibody (APX007), Anti-IL-6Ra / CD126 Reference Antibody (APX007), |
|||
A998887 | Anti-IL-6Ra / CD126 Reference Antibody (levilimab), Anti-IL-6Ra / CD126 Reference Antibody (levilimab), |
|||
A998888 | Anti-IL-6Ra / CD126 Reference Antibody (sapelizumab), Anti-IL-6Ra / CD126 Reference Antibody (sapelizumab), |
|||
A998889 | Anti-IL-6Ra / CD126 Reference Antibody (sarilumab), Anti-IL-6Ra / CD126 Reference Antibody (sarilumab), |
|||
A998890 | Anti-IL-6Ra / CD126 Reference Antibody (tocilizumab), Anti-IL-6Ra / CD126 Reference Antibody (tocilizumab), |
|||
A998891 | Anti-IL-6Ra / CD126 Reference Antibody (vobarilizumab), Anti-IL-6Ra / CD126 Reference Antibody (vobarilizumab), |
|||
A998892 | Anti-IL-7Ra / CD127 Reference Antibody (lusvertikimab), Anti-IL-7Ra / CD127 Reference Antibody (lusvertikimab), |
|||
A998893 | Anti-IL-7Ra / CD127 Reference Antibody (PF-06342674), Anti-IL-7Ra / CD127 Reference Antibody (PF-06342674), |
|||
A998894 | Anti-IL-9 Reference Antibody (enokizumab), Anti-IL-9 Reference Antibody (enokizumab), |
|||
A998895 | Anti-ILDR2 Reference Antibody (bapotulimab), Anti-ILDR2 Reference Antibody (bapotulimab), |
|||
A998896 | Anti-INHBA / Activin A Reference Antibody (garetosmab), Anti-INHBA / Activin A Reference Antibody (garetosmab), |
|||
A998897 | Anti-INHBB / Activin B Reference Antibody (Oxford Brookes U. patent anti-Activin Beta-B), Anti-INHBB / Activin B Reference Antibody (Oxford Brookes U. patent anti-Activin Beta-B), |
|||
A998898 | Anti-Integrin a11 / ITAG11 Reference Antibody (Scripps patent anti-CD11a), Anti-Integrin a11 / ITAG11 Reference Antibody (Scripps patent anti-CD11a), |
|||
A998899 | Anti-Integrin a2b1 (ITGA2 & ITGB1) Reference Antibody (vatelizumab), Anti-Integrin a2b1 (ITGA2 & ITGB1) Reference Antibody (vatelizumab), |
|||
A998900 | Anti-Integrin a2b3 (ITGA2 & ITGB3) Reference Antibody (tadocizumab), Anti-Integrin a2b3 (ITGA2 & ITGB3) Reference Antibody (tadocizumab), |
|||
A998901 | Anti-Integrin a4b7 (ITGA4 & ITGB7) Reference Antibody (abrilumab), Anti-Integrin a4b7 (ITGA4 & ITGB7) Reference Antibody (abrilumab), |
|||
A998902 | Anti-Integrin a4b7 (ITGA4 & ITGB7) Reference Antibody (etrolizumab), Anti-Integrin a4b7 (ITGA4 & ITGB7) Reference Antibody (etrolizumab), |